A detailed history of Armstrong Advisory Group, Inc transactions in Novartis Ag stock. As of the latest transaction made, Armstrong Advisory Group, Inc holds 100 shares of NVS stock, worth $10,428. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$10,428
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$92.57 - $107.37 $8,053 - $9,341
87 Added 669.23%
100 $10,000
Q1 2023

Apr 07, 2023

SELL
$80.03 - $92.81 $8,003 - $9,281
-100 Reduced 88.5%
13 $1,000
Q4 2022

Jan 17, 2023

BUY
$75.55 - $92.52 $8,537 - $10,454
113 New
113 $0

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Armstrong Advisory Group, Inc Portfolio

Follow Armstrong Advisory Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armstrong Advisory Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Armstrong Advisory Group, Inc with notifications on news.